Mr. Inas Said reports

RISE NANO OPTICS ANNOUNCES PROPOSED NON-BROKERED PRIVATE PLACEMENT OF UP TO C$5 MILLION

Rise Nano Optics Ltd. intends to complete a non-brokered private placement of up to 10 million units of the company at a price of 50 cents per unit for aggregate gross proceeds of up to $5-million.

Each unit will consist of one common share in the capital of the company and one common share purchase warrant. Each warrant will entitle its holder to acquire one additional share at an exercise price of $1 for a period of 24 months following the applicable closing date of the offering.

The company is targeting gross proceeds of up to $5-million, with a minimum aggregate financing amount of $3-million unless otherwise approved by the company. The company may accept subscriptions in whole or in part, and may complete the offering in one or more closings.

The company intends to use the net proceeds of the offering to advance the commercialization and expansion of its proprietary SpectraGuard lens technology, including sales, marketing and commercial distribution initiatives; development, deployment and support of optical laboratory and lens manufacturing partnerships; potential optical laboratory acquisitions; expansion of manufacturing and nano-material production capabilities; and product development, regulatory compliance and general working capital. Actual allocation of proceeds will depend on the amount raised and the company's operating requirements.

"This financing represents an important step in Rise Nano Optics' growth strategy as we transition from establishing our commercial foundation to expanding our market presence," said Inas Said, chief executive officer of Rise Nano Optics. "With SpectraGuard now entering commercial distribution through our optical laboratory partners, our focus is on accelerating adoption, expanding production capabilities and building the infrastructure needed to support long-term growth. The proceeds from this offering will provide additional resources to pursue these opportunities, including strategic partnerships and potential acquisitions, as we work to establish SpectraGuard as a differentiated lens technology in the global optical market."

The offering is expected to close on or about Dec. 15, 2026, or such other date or dates as the company may determine, subject to approval by the company's board of directors, compliance with applicable securities laws and Canadian Securities Exchange requirements, execution and acceptance of definitive subscription agreements, verification of investor eligibility, receipt of subscription funds, and other customary closing conditions. There can be no assurance that the offering will be completed, in whole or in part.

The offering will be conducted pursuant to applicable prospectus and registration exemptions, and will be available only to eligible investors in jurisdictions where the offering may lawfully be made. Securities issued under the offering will be subject to applicable resale restrictions, including any required Canadian hold period, U.S. securities law restrictions and CSE requirements. The company has not announced the payment of any finders' fees in connection with the offering.

About Rise Nano Optics Ltd.

Rise Nano Optics is a health technology company specializing in advanced nano-technology lens solutions designed to selectively filter high-energy visible light wavelengths. Its patented SpectraGuard technology integrates nano-material innovation, ophthalmic research and scalable optical engineering to serve both clinical and consumer eyewear markets globally.

We seek Safe Harbor.